Commentary: The 2001 anthrax attacks: Implications for the medical community and beyond

Clinics in Dermatology

Volumn 22, Issue 2, 2004, Pages 168-170

  Cole, Leonard A ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; AWARENESS; BACILLUS ANTHRACIS; DISEASE TRANSMISSION; EARLY DIAGNOSIS; HUMAN; MEDICAL SOCIETY; NOTE; POSTAL MAIL; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 3042615171     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.03.015     Document Type: Review

References (6)

1. Proceedings of the convention on the prohibition of the development, production and stockpiling of bacteriological (biological) and toxin weapons and on their destruction. Opened for signature at London, Moscow and Washington, DC, April 10, 1972; entered into force March 26, 1975
2. Alibek K. Biohazard: the chilling story of the largest covert biological weapons program in the world. 1999;Random House, New York
3. Jernigan D.B., et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 8:2002;1019-1028
4. Cole L.A. Clouds of secrecy: the army's germ warfare tests over populated areas. 1990;Rowman and Littlefield, Lanham, MD
5. Cole L.A. The anthrax letters: A medical detective story. 2003;Joseph Henry Press/National Academies Press, Washington, DC
6. Heller M.B., et al. Laboratory response to anthrax bioterrorism, New York City, 2001. Emerg Infect Dis. 8:2002;1096-1102